LivaNova PLC
LIVN
株式のランク
#3841
LivaNova PLC is a global medical technology company dedicated to developing,... LivaNova PLC is a global medical technology company dedicated to developing, manufacturing, and marketing a variety of therapeutic solutions. The company operates through three key segments. Its Cardiopulmonary division provides essential products for heart-lung procedures, such as oxygenators, heart-lung machines, and various perfusion systems. The Neuromodulation segment is known for its VNS Therapy System, an implantable device that delivers vagus nerve stimulation to treat drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. This segment is also advancing the VITARIA System, which employs VNS for heart failure, through clinical development. The Advanced Circulatory Support segment offers temporary life support solutions, including both cardiopulmonary and respiratory support technologies. LivaNova serves a wide range of medical professionals, including perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals and healthcare providers. The company's products are distributed globally through both its direct sales force and independent distributors. Additionally, LivaNova has a research collaboration with Verily aimed at discovering clinical biomarkers for depression. Founded in 1987, the company is headquartered in London, United Kingdom.
株価
$78.37
最終同期: 2026-10-19
時価総額
$4.31B
変化（1日）
1.02%
変化（1年）
44.86%
国
GB
取引 LivaNova PLC (LIVN)
カテゴリー
Healthcare
LivaNova PLC（LIVN）の営業利益率
October 2026 時点の営業利益率 TTM: 13.48%
LivaNova PLC の最新の財務報告と株価によると、現在の営業利益率（TTM）は 13.48% です。2023 年末時点では -5.94% でした。
LivaNova PLC の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 13.48% | 30.87% |
| 2024 | 10.30% | -273.40% |
| 2023 | -5.94% | -215.12% |
| 2022 | 5.16% | -5,833.33% |
| 2021 | -0.09% | -98.03% |
| 2020 | -4.58% | -203.39% |
| 2019 | 4.43% | -119.77% |
| 2018 | -22.41% | -337.14% |
| 2017 | 9.45% | -516.30% |
| 2016 | -2.27% | -107.46% |
| 2015 | 30.41% | -1.30% |
| 2013 | 30.81% | 10.47% |
| 2012 | 27.89% | 7.98% |
| 2011 | 25.83% | 17.57% |
| 2010 | 21.97% | 66.19% |
| 2009 | 13.22% | -294.70% |
| 2008 | -6.79% | -82.05% |
| 2007 | -37.82% | -21.18% |
| 2006 | -47.98% | 284.46% |
| 2005 | -12.48% | -306.28% |
| 2004 | 6.05% | 35.04% |
| 2003 | 4.48% | -111.54% |
| 2002 | -38.81% | 0.00% |
| 2001 | 0.00% | -100.00% |
| 2000 | -10.97% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.03% | -98.74% |
US
|
|
| 17.86% | -98.68% |
IE
|
|
| 22.03% | -98.37% |
US
|
|
| 21.46% | -98.41% |
US
|
|
| 0.00% | - |
DE
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。